Bacterial Infection Current Affairs - 2020
On April 20, 2020, the Drugs Controller General of India (DCGI) approved trial of a drug to reduce mortality rate of COVID-19 patients.
The COVID-19 drug that was developed by the Cadila Pharmaceuticals along with Council of Scientific and Industrial Research (CSIR) is to enter into trial. The clinical trial has been approved by DCGI. The drug had been used to treat critically ill patients suffering from Gram Negative Bacterial Sepsis.
Gram Negative Bacteria
Gram Negative Bacteria with Sepsis is a systematic disease that are caused by micro-organisms. It is common in children with weak immune system. Gram Negative Bacteria are those bacteria that have strong membranes around their cells than the gram positive bacteria. This makes them much more difficult to treat.
Sepsis is a life-threatening condition. Normally, human body released chemicals into the blood stream to fight an infection. When the chemicals in the bloodstream go out of balance, sepsis occurs;
Why used for COVID-19?
The patients suffering from COVID-19 and Gram Negative Bacterial Sepsis have similarities and hence the drug is being used to treat patients suffering from COVID-19. The drug used to treat Gram Negative Bacterial Sepsis has been proved to be safe and has not reported any systemic side effects so far.
Tags: Bacteria • Bacterial Infection • Clinical trials • Council of Scientific and Industrial Research (CSIR) • COVID-19
A new technology has been adopted by the Maharashtra hospitals in the fight of COVID-19 fight. The technology was developed by a Pune based Start Up.
What is the product?
The product developed is a Negative Ion Generator. It has been named “Scitech Airon”. It helps to control bacteria, virus and fungal infections. The product disinfects areas that were exposed to infections thereby it ensures well being of doctors, nurses and staffs in the hospital. The product is highly useful in quarantine facilities. The Department of Science and Technology has released Rs 1 crore to manufacture the product in a larger scale. Around 1,000 of them are to be produced soon.
The technology was developed under “NIDHI PRAYAS” programme of Department of Science and Technology.
The Scitech Airon machine creates negatively charged ions. These ions form clusters around viruses, bacteria and other airborne molds. They then render them inactive through chemical reactions by creating Hydroxyl radicals (OH) groups. Apart from pathogens, the machine also decomposes harmful pollutants such as Carbon Monoxide, Nitrogen dioxide, etc.
There is lack of support in the early stages of prototyping in the country/ This causes many innovators to lose interest in the early stages. PRAYAS is Promoting and Accelerating Young and Aspiring technology entrepreneurs. It is one of the 9 programmes launched to turn the ideas of young innovators into proof of concepts.